Atlas Trials

Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord

Clinical trial NCT03562065 · UNKNOWN

Trial details

NCT number
NCT03562065
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lupus ErythematosusStem Cell Transplant
Start date
2019-09-11
Primary completion
2023-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.